BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36611187)

  • 1. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
    Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
    J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.
    Shkreta L; Delannoy A; Salvetti A; Chabot B
    RNA; 2021 Nov; 27(11):1302-1317. PubMed ID: 34315816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
    Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF
    Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
    Blázquez-Encinas R; García-Vioque V; Caro-Cuenca T; Moreno-Montilla MT; Mangili F; Alors-Pérez E; Ventura S; Herrera-Martínez AD; Moreno-Casado P; Calzado MA; Salvatierra Á; Gálvez-Moreno MA; Fernandez-Cuesta L; Foll M; Luque RM; Alcala N; Pedraza-Arevalo S; Ibáñez-Costa A; Castaño JP
    J Transl Med; 2023 Dec; 21(1):879. PubMed ID: 38049848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors.
    Shkreta L; Toutant J; Durand M; Manley JL; Chabot B
    Cell Rep; 2016 Nov; 17(8):1990-2003. PubMed ID: 27851963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia.
    Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H
    DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SRSF10 as a regulator of SMN2 ISS-N1.
    Frederiksen SB; Holm LL; Larsen MR; Doktor TK; Andersen HS; Hastings ML; Hua Y; Krainer AR; Andresen BS
    Hum Mutat; 2021 Mar; 42(3):246-260. PubMed ID: 33300159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.
    Cloutier A; Shkreta L; Toutant J; Durand M; Thibault P; Chabot B
    Sci Rep; 2018 Feb; 8(1):2206. PubMed ID: 29396485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma.
    An W; Yang Q; Xi Y; Pan H; Huang H; Chen Q; Wang Y; Hua D; Shi C; Wang Q; Sun C; Luo W; Li X; Yu S; Zhou X
    Life Sci; 2024 Feb; 338():122392. PubMed ID: 38160788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CASH: a constructing comprehensive splice site method for detecting alternative splicing events.
    Wu W; Zong J; Wei N; Cheng J; Zhou X; Cheng Y; Chen D; Guo Q; Zhang B; Feng Y
    Brief Bioinform; 2018 Sep; 19(5):905-917. PubMed ID: 28387786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRSF10 Plays a Role in Myoblast Differentiation and Glucose Production via Regulation of Alternative Splicing.
    Wei N; Cheng Y; Wang Z; Liu Y; Luo C; Liu L; Chen L; Xie Z; Lu Y; Feng Y
    Cell Rep; 2015 Nov; 13(8):1647-57. PubMed ID: 26586428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia.
    Liu J; Huang B; Xiao Y; Xiong HM; Li J; Feng DQ; Chen XM; Zhang HB; Wang XZ
    Onkologie; 2012; 35(6):335-40. PubMed ID: 22722453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Srsf10 and the minor spliceosome control tissue-specific and dynamic SR protein expression.
    Meinke S; Goldammer G; Weber AI; Tarabykin V; Neumann A; Preussner M; Heyd F
    Elife; 2020 Apr; 9():. PubMed ID: 32338600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
    Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
    Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.
    Chang C; Rajasekaran M; Qiao Y; Dong H; Wang Y; Xia H; Deivasigamani A; Wu M; Sekar K; Gao H; Sun M; Niu Y; Li Q; Tao L; Yan Z; Wang M; Chen S; Zhao S; Chen D; Li L; Yang F; Gao H; Chen B; Su L; Xu L; Chen Y; Seshachalam VP; Chen G; Gunaratne J; Hong W; Shi J; Chen G; Grierson DS; Chabot B; Xie T; Hui KM; Chen J
    Nat Commun; 2022 Mar; 13(1):1363. PubMed ID: 35296659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication.
    Shkreta L; Blanchette M; Toutant J; Wilhelm E; Bell B; Story BA; Balachandran A; Cochrane A; Cheung PK; Harrigan PR; Grierson DS; Chabot B
    Nucleic Acids Res; 2017 Apr; 45(7):4051-4067. PubMed ID: 27928057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
    Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
    Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
    Liu X; Shen S; Zhu L; Su R; Zheng J; Ruan X; Shao L; Wang D; Yang C; Liu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):121. PubMed ID: 32600379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
    Jin P; Tan Y; Zhang W; Li J; Wang K
    Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.